InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Kay Christina. Director active across 1 company, notably Integrated Biopharma INC. Cumulatively, 4 filings have been logged. Activity tracked since 30 May 2023. The latest transaction was disclosed on 21 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
KAY CHRISTINA is a declarant linked to Integrated Biopharma INC (XNAS). She has 4 filings in total, and the sampled recent filings run from 2023-06-01 to 2025-05-22, with transaction nature shown as Attribution and buy and sell amounts of EUR 0 in this sample.